Alex Duncan

Alex Duncan

Company: Walden Biosciences

Job title: Chief Scientific Officer

Seminars:

Proteomic Insights Into Causality & WAL0921 Treatment Effects in suPARDriven CKD 2:30 pm

Further evidence for suPAR driven progression in rare kidney disease indications WAL0921 as a suPAR reducing agent in kidney therapy Proteomic data insights into mechanism of action of anti-suPAR treatmentRead more

day: Conference Day One

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

 

Conferences Beacon
Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.